Delivery Order SPE2DE21D7020-SPE2D625F4EE2
- Not listed
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a fixed-price delivery order valued at $18,134.55 for agent drug-coated balloons by the Defense Health Agency's Medical Supply Chain on August 8, 2025. The delivery order, which carries an ultimate completion date of August 15, 2025, represents a competitive award with no set-aside designation. The contract employs fixed-price pricing with economic price adjustment mechanisms...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $18,953.95 for agent drug-coated balloon supplies. The contract, awarded on June 6, 2025, with an ultimate completion date of June 11, 2025, is funded through the Defense Health Agency's Medical Supply Chain division. This fixed-price contract with economic price adjustment represents Boston Scientific's continued role as a critical supplier...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $22,101.25 for drug-coated balloons under a Defense Health Agency Medical Supply Chain contract. The award, issued on May 30, 2025, with an ultimate completion date of June 6, 2025, represents a fixed-price contract with economic price adjustment provisions. The contract is not set aside for any specific business category and will be performed at...
- Boston Scientific Corp has been awarded a delivery order valued at $8,150.20 for agent drug-coated balloons under a Defense Health Agency Medical Supply Chain contract. The award, issued on September 16, 2025, with a completion date of September 19, 2025, utilizes fixed-price pricing with economic price adjustment terms. The contract carries no set-aside designation, indicating open competition in the federal marketplace. Performance will be executed at Boston Scientific's Marlborough,...
- Boston Scientific Corp has been awarded a delivery order valued at $6,175.00 for agent drug-coated balloons under the Defense Health Agency's Medical Supply Chain contract vehicle. The award, issued on August 15, 2025, with an ultimate completion date of August 22, 2025, represents a fixed-price contract with economic price adjustment provisions. The work will be performed at Boston Scientific's facility in Marlborough, Massachusetts, the company's headquarters location. This delivery order...
- Boston Scientific Corp has been awarded a delivery order by the Defense Health Agency's Medical Supply Chain for agent drug-coated balloons, with a contract ceiling value of $6,175. The award, issued on August 21, 2025, with an ultimate completion date of August 28, 2025, is structured as a fixed-price contract with economic price adjustment provisions. The place of performance is Boston Scientific's headquarters in Marlborough, Massachusetts. This delivery order represents no set-aside...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a fixed-price delivery order valued at $55,947.15 by the Defense Health Agency's Medical Supply Chain on July 29, 2025, with an ultimate completion date of August 5, 2025. The contract, which carries no set-aside designation, calls for the delivery of Ranger Global DCB (drug-coated balloon) devices measuring 4.0 x 120mm with a 150cm length. Performance will take place at Boston...
- Boston Scientific Corp has been awarded a $48,157.20 fixed-price delivery order with economic price adjustment by the Defense Health Agency's Medical Supply Chain for agent drug-coated balloons. The contract, issued on September 8, 2025, carries an ultimate completion date of September 15, 2025, and will be performed at Boston Scientific's facility in Marlborough, Massachusetts. This delivery order represents a non-set-aside award, indicating open competition in the federal marketplace, and...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order valued at $26,532.60 to Boston Scientific Corp for agent drug-coated balloon medical devices. The contract, issued on August 18, 2025, carries a fixed-price pricing structure with economic price adjustment provisions and has an ultimate completion date of August 25, 2025. This delivery order represents a continuation of Boston Scientific's role as a key supplier of specialized cardiovascular intervention equipment to...
- The Defense Health Agency's Medical Supply Chain has awarded a delivery order to Boston Scientific Corp for agent drug-coated balloons, with a ceiling value of approximately $19.9K and an ultimate completion date of September 22, 2025. This fixed-price contract with economic price adjustment provisions was awarded on September 15, 2025, with no set-aside designation, allowing Boston Scientific to compete openly in the federal marketplace. The work will be performed at Boston Scientific's...
- SPE2DE21D7020Indefinite Delivery Contract
- SPE2DE21D7020-SPE2D625F4EE2Delivery Order
Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $18,918.66 for agent drug-coated balloons by the Defense Health Agency's Medical Supply Chain on June 27, 2025. The contract is structured as a fixed-price agreement with economic price adjustment provisions and carries an ultimate completion date of July 7, 2025. The place of performance is located in Marlborough, MA, where Boston Scientific manufactures its cardiovascular intervention devices. No set-aside designation was applied to this award, indicating that the contract was competed openly in the federal marketplace. This delivery order represents a continuation of Boston Scientific's extensive federal contracting relationship with the Defense Health Agency and related defense healthcare entities. The company maintains a robust portfolio of federal contracts for specialized medical devices, including cardiovascular interventions, diagnostic tools, and other advanced medical technologies supplied to defense healthcare agencies. The drug-coated balloon delivery under this order supports the Defense Health Agency's medical supply requirements for interventional cardiology and vascular procedures, reflecting Boston Scientific's critical role as a supplier of innovative medical technologies to federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.9k | 6/27/25 |